+86-13031714605
info@millionpharm.com

  • Company
    • About us

    • Partners

    • Value

    • Careers

  • Product
    • Pharmaceutical API

    • Advanced Intermediate

  • R&D&Site
  • News&Events
  • Sustainability
  • Contact Us

PRODUCTS


Home > Products > Advanced Intermediates > Baricitinib Intermediate
  • 50-5;3-Azetidineacetonitrile, 1-(ethylsulfonyl)-3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]-
    50-5;3-Azetidineacetonitrile, 1-(ethylsulfonyl)-3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]-
  •  21-8;tert-butyl 4-chloro-7H-pyrrolo[2,3-d]pyrimidine-7-carboxylate
    21-8;tert-butyl 4-chloro-7H-pyrrolo[2,3-d]pyrimidine-7-carboxylate
  • 13-0;4-[1-[3-(cyanomethyl)-1-(ethylsulfonyl)-3-azetidinyl]-1H-pyrazol-4-yl]-7H-Pyrrolo[2,3-d]pyrimidine-7-carboxylic acid 1,1-dimethylethyl ester
    13-0;4-[1-[3-(cyanomethyl)-1-(ethylsulfonyl)-3-azetidinyl]-1H-pyrazol-4-yl]-7H-Pyrrolo[2,3-d]pyrimidine-7-carboxylic acid 1,1-dimethylethyl ester
  • 08-4;4-Pyrazoleboronic acid pinacol ester
    08-4;4-Pyrazoleboronic acid pinacol ester
  • 85-2;2-(1-(ethylsulfonyl)azetidin-3-ylidene)acetonitrile
    85-2;2-(1-(ethylsulfonyl)azetidin-3-ylidene)acetonitrile
    • 

      Cerebro-cardiovascular

    • 

      Central nervous system

    • 

      Cancer/tumor

    • 

      Anti-diabetics

    • 

      R&D&Pipeline

    • 

      Other APIS

    • 

      Peptides

    • 

      Supplements

    • 

      Sexual Enhancement

    • 

      Apixabn intermediates

    • 

      Bexagliflozin Intermediate

    • 

      Lurasidon intermediates

    • 

      Vortioxeti intermediates

    • 

      Selpercatinib intermediates

    • 

      Indacater intermediates

    • 

      Elacestrant intermediates

    • 

      Repotrectinib/TPX-0005 intermediate

    • 

      Baricitinib Intermediate

    • 

      Ropsacitinib intermediate

    • 

      Other intermediates

    WELCOME

    +86-13031714605
    info@millionpharm.com
    +86-13031714605

    Products

    • Pharmaceutical API

      • Cerebro-cardiovascular

      • Central nervous system

      • Cancer/tumor

      • Anti-diabetics

      • R&D&Pipeline

      • Other APIS

    • Advanced Intermediates

    • Company

      • About us

      • Partners

      • Value

      • Careers

    • R&D&Site

    • News&Events

    • Sustainability

    Contact Us

    Jinan Million Pharmaceutical Co., Ltd

    (Jinan Milin Pharmaceutical Co., Ltd)

    +86-13031714605 (Wechat)
    +86-13031714605
    +86-531-68659554
    info@millionpharm.com
    Room1-2208, Gaoxin district, Jinan, Shandong
     3299907431

    Attention: All products are only for research

    © million | All Rights Reserved

    Leave A Message

    If you are interested in our products and want to know more details, please leave a message here, we will reply you as soon as we can.

    SUBMIT
    
    
    +86-13031714605
    
    WhatsApp
    
    Email
    
    Inquiry
    